Long-term follow-up and post-relapse survival in patients with non-metastatic osteosarcoma of the extremity treated with neoadjuvant chemotherapy
Open Access
- 1 August 1997
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 8 (8) , 765-771
- https://doi.org/10.1023/a:1008221713505
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Methotrexate Serum Concentration and Histological Response to Multiagent Primary Chemotherapy for Osteosarcoma of the LimbsJournal of Chemotherapy, 1996
- Methotrexate pharmacokinetics and prognosis in osteosarcoma.Journal of Clinical Oncology, 1994
- Serum Methotrexate (MTX) Concentrations and Prognosis in Patients with Osteosarcoma of the Extremities Treated with a Multidrug Neoadjuvant RegimenJournal of Chemotherapy, 1993
- A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: the first study of the European Osteosarcoma Intergroup.Journal of Clinical Oncology, 1992
- Survival, prognosis, and therapeutic response in osteogenic sarcoma. The memorial hospital experienceCancer, 1992
- Die Chemotherapie des OsteosarkomsZeitschrift für Orthopädie und ihre Grenzgebiete, 1992
- Adjuvant Chemotherapy of High-Grade Osteosarcoma of the ExtremityClinical Orthopaedics and Related Research, 1991
- Patterns of Recurrence After Resection of Osteosarcoma of the ExtremityArchives of Surgery, 1989
- Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial.Journal of Clinical Oncology, 1987
- The Effect of Adjuvant Chemotherapy on Relapse-Free Survival in Patients with Osteosarcoma of the ExtremityNew England Journal of Medicine, 1986